Antibiotic Resistance Among Uropathogenic Escherichia coli

Abd El Ghany M, Sharaf H, Al-agamy MH, Shibl A, Hill-Cawthorne GA, Hong PY. Genomic characterization of NDM-1 and 5, and OXA-181 carbapenemases in uropathogenic Escherichia coli isolates from Riyadh, Saudi Arabia. PLoS One. 2018 Aug 15; 13(8):e0201613. https://doi.org/10.1371/journal.pone.0201613Abd El GhanyMSharafHAl-agamyMHShiblAHill-CawthorneGAHongPY.Genomic characterization of NDM-1 and 5, and OXA-181 carbapenemases in uropathogenic Escherichia coli isolates from Riyadh, Saudi Arabia. PLoS One.2018Aug 15; 13(8):e0201613. https://doi.org/10.1371/journal.pone.020161310.1371/journal.pone.0201613609366030110357Search in Google Scholar

Abdelhamid SM, Abozahra RR. Expression of the fluoroquinolones efflux pump genes acrA and mdfA in urinary Escherichia coli isolates. Pol J Microbiol. 66(1):25–30.AbdelhamidSMAbozahraRR.Expression of the fluoroquinolones efflux pump genes acrA and mdfA in urinary Escherichia coli isolates. Pol J Microbiol.66(1):25–30.10.5604/17331331.123499029359692Search in Google Scholar

Abduzaimovic A, Aljicevic M, Rebic V, Vranic S, Abduzaimovic K, Sestic S. Antibiotic resistance in urinary isolates of Escherichia coli. Mater Sociomed. 2016;28(6):416–419. https://doi.org/10.5455/msm.2016.28.416-419AbduzaimovicAAljicevicMRebicVVranicSAbduzaimovicKSesticS.Antibiotic resistance in urinary isolates of Escherichia coli. Mater Sociomed.2016;28(6):416–419. https://doi.org/10.5455/msm.2016.28.416-41910.5455/msm.2016.28.416-419523964728144190Search in Google Scholar

Abernethy J, Guy R, Sheridan EA, Hopkins S, Kiernan M, Wilcox MH, Johnson AP, Hope R. E. coli bacteraemia sentinel surveillance group. Epidemiology of Escherichia coli bacteraemia in England: results of an enhanced sentinel surveillance programme. J Hosp Infect. 2017;95(4):365–375. https://doi.org/10.1016/j.jhin.2016.12.008AbernethyJGuyRSheridanEAHopkinsSKiernanMWilcoxMHJohnsonAPHopeR.E. coli bacteraemia sentinel surveillance group.Epidemiology of Escherichia coli bacteraemia in England: results of an enhanced sentinel surveillance programme. J Hosp Infect.2017;95(4):365–375. https://doi.org/10.1016/j.jhin.2016.12.00810.1016/j.jhin.2016.12.00828190700Search in Google Scholar

Adams-Sapper S, Diep BA, Perdreau-Remington F, Riley LW. Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections. Antimicrob Agents Chemother. 2013 Jan;57(1):490–497. https://doi.org/10.1128/AAC.01025-12Adams-SapperSDiepBAPerdreau-RemingtonFRileyLW.Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections. Antimicrob Agents Chemother.2013Jan;57(1):490–497. https://doi.org/10.1128/AAC.01025-1210.1128/AAC.01025-12353597523147723Search in Google Scholar

Adamus-Białek W, Baraniak A, Wawszczak M, Głuszek S, Gad B, Wróbel K, Bator P, Majchrzak M, Parniewski P. The genetic background of antibiotic resistance among clinical uropathogenic Escherichia coli strains. Mol Biol Rep. 2018 Oct;45(5):1055–1065. https://doi.org/10.1007/s11033-018-4254-0Adamus-BiałekWBaraniakAWawszczakMGłuszekSGadBWróbelKBatorPMajchrzakMParniewskiP.The genetic background of antibiotic resistance among clinical uropathogenic Escherichia coli strains. Mol Biol Rep.2018Oct;45(5):1055–1065. https://doi.org/10.1007/s11033-018-4254-010.1007/s11033-018-4254-0615676030008141Search in Google Scholar

Alghoribi MF, Gibreel TM, Farnham G, Al Johani SM, Balkhy HH, Upton M. Antibiotic-resistant ST38, ST131 and ST405 strains are the leading uropathogenic Escherichia coli clones in Riyadh, Saudi Arabia. J Antimicrob Chemother. 2015 Oct;70(10):2757–2762. https://doi.org/10.1093/jac/dkv188AlghoribiMFGibreelTMFarnhamGAl JohaniSMBalkhyHHUptonM.Antibiotic-resistant ST38, ST131 and ST405 strains are the leading uropathogenic Escherichia coli clones in Riyadh, Saudi Arabia. J Antimicrob Chemother.2015Oct;70(10):2757–2762. https://doi.org/10.1093/jac/dkv18810.1093/jac/dkv18826183183Search in Google Scholar

Ali I, Rafaque Z, Ahmed S, Malik S, Dasti JI. Prevalence of multidrug resistant uropathogenic Escherichia coli in Potohar region of Pakistan. Asian Pac J Trop Biomed. 2016 Jan;6(1):60–66. https://doi.org/10.1016/j.apjtb.2015.09.022AliIRafaqueZAhmedSMalikSDastiJI.Prevalence of multidrug resistant uropathogenic Escherichia coli in Potohar region of Pakistan. Asian Pac J Trop Biomed.2016Jan;6(1):60–66. https://doi.org/10.1016/j.apjtb.2015.09.02210.1016/j.apjtb.2015.09.022Search in Google Scholar

Asadi Karam MR, Habibi M, Bouzari S. Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli. Mol Immunol. 2019 Apr;108:56–67. https://doi.org/10.1016/j.molimm.2019.02.007Asadi KaramMRHabibiMBouzariS.Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli. Mol Immunol.2019Apr;108:56–67. https://doi.org/10.1016/j.molimm.2019.02.00710.1016/j.molimm.2019.02.00730784763Search in Google Scholar

Bahagon Y, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM. Prevalence and predictive features of bacteremic urinary tract infection in emergency department patients. Eur J Clin Microbiol Infect Dis. 2007 May 4;26(5):349–352. https://doi.org/10.1007/s10096-007-0287-3BahagonYRavehDSchlesingerYRudenskyBYinnonAM.Prevalence and predictive features of bacteremic urinary tract infection in emergency department patients. Eur J Clin Microbiol Infect Dis.2007May 4;26(5):349–352. https://doi.org/10.1007/s10096-007-0287-310.1007/s10096-007-0287-317431694Search in Google Scholar

Banerjee R, Johnson JR. A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131. Antimicrob Agents Chemother. 2014 Sep;58(9):4997–5004. https://doi.org/10.1128/AAC.02824-14BanerjeeRJohnsonJR.A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131. Antimicrob Agents Chemother.2014Sep;58(9):4997–5004. https://doi.org/10.1128/AAC.02824-1410.1128/AAC.02824-14413587924867985Search in Google Scholar

Bartoletti R, Cai T, Wagenlehner FM, Naber K, Bjerklund Johansen TE. Treatment of urinary tract infections and antibiotic stewardship. Eur Urol Suppl. 2016 Jul;15(4):81–87. https://doi.org/10.1016/j.eursup.2016.04.003BartolettiRCaiTWagenlehnerFMNaberKBjerklund JohansenTE.Treatment of urinary tract infections and antibiotic stewardship. Eur Urol Suppl.2016Jul;15(4):81–87. https://doi.org/10.1016/j.eursup.2016.04.00310.1016/j.eursup.2016.04.003Search in Google Scholar

Baudry PJ, Nichol K, DeCorby M, Lagacé-Wiens P, Olivier E, Boyd D, Mulvey MR, Hoban DJ, Zhanel GG. Mechanisms of resistance and mobility among multidrug-resistant CTX-M-producing Escherichia coli from Canadian intensive care units: the 1st report of QepA in North America. Diagn Microbiol Infect Dis. 2009 Mar;63(3):319–326. https://doi.org/10.1016/j.diagmicrobio.2008.12.001BaudryPJNicholKDeCorbyMLagacé-WiensPOlivierEBoydDMulveyMRHobanDJZhanelGG.Mechanisms of resistance and mobility among multidrug-resistant CTX-M-producing Escherichia coli from Canadian intensive care units: the ^1st report of QepA in North America. Diagn Microbiol Infect Dis.2009Mar;63(3):319–326. https://doi.org/10.1016/j.diagmicrobio.2008.12.00110.1016/j.diagmicrobio.2008.12.00119216943Search in Google Scholar

Bhat MA, Sageerabanoo S, Kowsalya R, Sarkar G. The occurrence of CTX-M3 type extended spectrum beta lactamases among Escherichia coli causing urinary tract infections in a tertiary care hospital in puducherry. J Clin Diagn Res. 2012;6(7):1203–1206.BhatMASageerabanooSKowsalyaRSarkarG.The occurrence of CTX-M3 type extended spectrum beta lactamases among Escherichia coli causing urinary tract infections in a tertiary care hospital in puducherry. J Clin Diagn Res.2012;6(7):1203–1206.Search in Google Scholar

Bischoff S, Walter T, Gerigk M, Ebert M, Vogelmann R. Empiric antibiotic therapy in urinary tract infection in patients with risk factors for antibiotic resistance in a German emergency department. BMC Infect Dis. 2018 Dec;18(1):56. https://doi.org/10.1186/s12879-018-2960-9BischoffSWalterTGerigkMEbertMVogelmannR.Empiric antibiotic therapy in urinary tract infection in patients with risk factors for antibiotic resistance in a German emergency department. BMC Infect Dis.2018Dec;18(1):56. https://doi.org/10.1186/s12879-018-2960-910.1186/s12879-018-2960-9578727329373965Search in Google Scholar

Blaettler L, Mertz D, Frei R, Elzi L, Widmer AF, Battegay M, Flückiger U. Secular trend and risk factors for antimicrobial resistance in Escherichia coli isolates in Switzerland 1997–2007. Infection. 2009 Dec;37(6):534–539. https://doi.org/10.1007/s15010-009-8457-0BlaettlerLMertzDFreiRElziLWidmerAFBattegayMFlückigerU.Secular trend and risk factors for antimicrobial resistance in Escherichia coli isolates in Switzerland 1997–2007. Infection.2009Dec;37(6):534–539. https://doi.org/10.1007/s15010-009-8457-010.1007/s15010-009-8457-020013094Search in Google Scholar

Bonkat G, Pickard R, Bartoletti R, Bruyère F, Geerlings SE, Wagenlehner F, Wullt B. Guidelines on urological infections [Internet]. Arnhem (The Netherlands): European Association of Urology; 2017 [cited 2019 May 31]. Available from https://uroweb.org/wp-content/uploads/Urological-Infections-2017-pocket.pdfBonkatGPickardRBartolettiRBruyèreFGeerlingsSEWagenlehnerFWulltB.Guidelines on urological infections [Internet]. Arnhem (The Netherlands): European Association of Urology; 2017 [cited 2019 May 31]. Available from https://uroweb.org/wp-content/uploads/Urological-Infections-2017-pocket.pdfSearch in Google Scholar

Brumbaugh AR, Smith SN, Mobley HLT. Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection. Infect Immun. 2013 Sep; 81(9):3309–3316. https://doi.org/10.1128/IAI.00470-13BrumbaughARSmithSNMobleyHLT.Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection. Infect Immun.2013Sep; 81(9):3309–3316. https://doi.org/10.1128/IAI.00470-1310.1128/IAI.00470-13375420223798537Search in Google Scholar

Cek M, Tandoğdu Z, Wagenlehner F, Tenke P, Naber K, Bjerklund-Johansen TE. Healthcare-associated urinary tract infections in hospitalized urological patients – a global perspective: results from the GPIU studies 2003–2010. World J Urol. 2014 Dec;32(6):1587–1594. https://doi.org/10.1007/s00345-013-1218-9CekMTandoğduZWagenlehnerFTenkePNaberKBjerklund-JohansenTE.Healthcare-associated urinary tract infections in hospitalized urological patients – a global perspective: results from the GPIU studies 2003–2010. World J Urol.2014Dec;32(6):1587–1594. https://doi.org/10.1007/s00345-013-1218-910.1007/s00345-013-1218-924452449Search in Google Scholar

Cheung A, Karmali G, Noble S, Song H. Antimicrobial stewardship initiative in treatment of urinary tract infections at a rehabilitation and complex continuing care hospital. Can J Hosp Pharm. 2017 Apr 28;70(2):144–149. https://doi.org/10.4212/cjhp.v70i2.1648CheungAKarmaliGNobleSSongH.Antimicrobial stewardship initiative in treatment of urinary tract infections at a rehabilitation and complex continuing care hospital. Can J Hosp Pharm.2017Apr 28;70(2):144–149. https://doi.org/10.4212/cjhp.v70i2.164810.4212/cjhp.v70i2.1648540742428487582Search in Google Scholar

Ciontea AS, Cristea D, Andrei MM, Popa A, Usein CR. In vitro antimicrobial resistance of urinary Escherichia coli isolates from outpatients collected in a laboratory during two years, 2015–2017. Roum Arch Microbiol Immunol. 2018;77(1):28–32.CionteaASCristeaDAndreiMMPopaAUseinCR.In vitro antimicrobial resistance of urinary Escherichia coli isolates from outpatients collected in a laboratory during two years, 2015–2017. Roum Arch Microbiol Immunol.2018;77(1):28–32.Search in Google Scholar

Cristea VC, Gheorghe I, Barbu IC, Popa LI, Ispas B, Grigore GA, Bucatariu I, Popa GL, Angelescu M-C, Velican A, et al. Snapshot of phylogenetic groups, virulence, and esistance markers in Escherichia coli uropathogenic strains isolated from outpatients with urinary tract infections in Bucharest, Romania. BioMed Res Int. 2019;Article ID 5712371, 8 pages. https://doi.org/10.1155/2019/5712371CristeaVCGheorgheIBarbuICPopaLIIspasBGrigoreGABucatariuIPopaGLAngelescuM-CVelicanA, Snapshot of phylogenetic groups, virulence, and esistance markers in Escherichia coli uropathogenic strains isolated from outpatients with urinary tract infections in Bucharest, Romania. BioMed Res Int.2019;Article ID 5712371, 8 pages. https://doi.org/10.1155/2019/571237110.1155/2019/5712371654581231236408Search in Google Scholar

Cunha MA, Assunção GLM, Medeiros IM, Freitas MR. Antibiotic resistance patterns of urinary tract infections in a northeastern Brazilian capital. Rev Inst Med Trop São Paulo. 2016;58(0):2. https://doi.org/10.1590/S1678-9946201658002CunhaMAAssunçãoGLMMedeirosIMFreitasMR.Antibiotic resistance patterns of urinary tract infections in a northeastern Brazilian capital. Rev Inst Med Trop São Paulo.2016;58(0):2. https://doi.org/10.1590/S1678-994620165800210.1590/S1678-9946201658002479394326910446Search in Google Scholar

Dashti AA, West P, Paton R, Amyes SG. Characterization of extended-spectrum-lactamase (ESBL)-producing Kuwait and UK strains identified by the Vitek system, and subsequent comparison of the Vitek system with other commercial ESBL-testing systems using these strains. J Med Microbiol. 2006 Apr 01;55(4):417–421. https://doi.org/10.1099/jmm.0.46177-0DashtiAAWestPPatonRAmyesSG.Characterization of extended-spectrum-lactamase (ESBL)-producing Kuwait and UK strains identified by the Vitek system, and subsequent comparison of the Vitek system with other commercial ESBL-testing systems using these strains. J Med Microbiol.2006Apr 01;55(4):417–421. https://doi.org/10.1099/jmm.0.46177-010.1099/jmm.0.46177-016533989Search in Google Scholar

Delpech G, Allende NG, Lissarrague S, Sparo M. Antimicrobial resistance of uropathogenic Escherichia coli from elderly patients at a general hospital, Argentina. Open Infect Dis J. 2018 Jul 19;10(1):79–87. https://doi.org/10.2174/1874279301810010079DelpechGAllendeNGLissarragueSSparoM.Antimicrobial resistance of uropathogenic Escherichia coli from elderly patients at a general hospital, Argentina. Open Infect Dis J.2018Jul 19;10(1):79–87. https://doi.org/10.2174/187427930181001007910.2174/1874279301810010079Search in Google Scholar

Dijkmans AC, Zacarías NVO, Burggraaf J, Mouton JW, Wilms E, van Nieuwkoop C, Touw DJ, Stevens J, Kamerling IMC. Fosfomycin: pharmacological, clinical and future perspectives. Antibiotics (Basel). 2017 Oct 31;6(4):24. https://doi.org/10.3390/antibiotics6040024DijkmansACZacaríasNVOBurggraafJMoutonJWWilmsEvan NieuwkoopCTouwDJStevensJKamerlingIMC.Fosfomycin: pharmacological, clinical and future perspectives. Antibiotics (Basel).2017Oct 31;6(4):24. https://doi.org/10.3390/antibiotics604002410.3390/antibiotics6040024574546729088073Search in Google Scholar

Drekonja DM, Rector TS, Cutting A, Johnson JR. Urinary tract infection in male veterans: treatment patterns and outcomes. JAMA Intern Med. 2013 Jan 14;173(1):62–68. https://doi.org/10.1001/2013.jamainternmed.829DrekonjaDMRectorTSCuttingAJohnsonJR.Urinary tract infection in male veterans: treatment patterns and outcomes. JAMA Intern Med.2013Jan 14;173(1):62–68. https://doi.org/10.1001/2013.jamainternmed.82910.1001/2013.jamainternmed.82923212273Search in Google Scholar

Erb S, Frei R, Tschudin Sutter S, Egli A, Dangel M, Bonkat G, Widmer AF. Basic patient characteristics predict antimicrobial resistance in E. coli from urinary tract specimens: a retrospective cohort analysis of 5246 urine samples. Swiss Med Wkly. 2018 Nov 15;148:w14660. https://doi.org/10.4414/smw.2018.14660ErbSFreiRTschudin SutterSEgliADangelMBonkatGWidmerAF.Basic patient characteristics predict antimicrobial resistance in E. coli from urinary tract specimens: a retrospective cohort analysis of 5246 urine samples. Swiss Med Wkly.2018Nov 15;148:w14660. https://doi.org/10.4414/smw.2018.1466010.4414/smw.2018.1466030440065Search in Google Scholar

ECDCP. Point prevalence survey of healthcare associated infections and antimicrobial use in European Acute Care Hospitals, 2011–2012. Stockholm (Sweden): European Center for Disease Control and Prevention; 2013.ECDCP.Point prevalence survey of healthcare associated infections and antimicrobial use in European Acute Care Hospitals, 2011–2012. Stockholm (Sweden): European Center for Disease Control and Prevention; 2013.Search in Google Scholar

Faghri J, Dehbanipour R, Rastaghi S, Sedighi M, Maleki N. High prevalence of multidrug-resistance uropathogenic Escherichia coli strains, Isfahan, Iran. J Nat Sci Biol Med. 2016;7(1):22–26. https://doi.org/10.4103/0976-9668.175020FaghriJDehbanipourRRastaghiSSedighiMMalekiN.High prevalence of multidrug-resistance uropathogenic Escherichia coli strains, Isfahan, Iran. J Nat Sci Biol Med.2016;7(1):22–26. https://doi.org/10.4103/0976-9668.17502010.4103/0976-9668.175020478016127003964Search in Google Scholar

Fasugba O, Gardner A, Mitchell BG, Mnatzaganian G. Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies. BMC Infect Dis. 2015 Dec;15(1):545. https://doi.org/10.1186/s12879-015-1282-4FasugbaOGardnerAMitchellBGMnatzaganianG.Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies. BMC Infect Dis.2015Dec;15(1):545. https://doi.org/10.1186/s12879-015-1282-410.1186/s12879-015-1282-4466078026607324Search in Google Scholar

Filippini M, Masiero G, Moschetti K. Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland. Health Policy. 2006 Aug;78(1):77–92. https://doi.org/10.1016/j.healthpol.2005.09.009FilippiniMMasieroGMoschettiK.Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland. Health Policy.2006Aug;78(1):77–92. https://doi.org/10.1016/j.healthpol.2005.09.00910.1016/j.healthpol.2005.09.00916290129Search in Google Scholar

Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015 May;13(5):269–284. https://doi.org/10.1038/nrmicro3432Flores-MirelesALWalkerJNCaparonMHultgrenSJ.Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol.2015May;13(5):269–284. https://doi.org/10.1038/nrmicro343210.1038/nrmicro3432445737725853778Search in Google Scholar

Friedman SM, Lu T, Drlica K. Mutation in the DNA gyrase A Gene of Escherichia coli that expands the quinolone resistance-determining region. Antimicrob Agents Chemother. 2001 Aug 01; 45(8):2378–2380. https://doi.org/10.1128/AAC.45.8.2378-2380.2001FriedmanSMLuTDrlicaK.Mutation in the DNA gyrase A Gene of Escherichia coli that expands the quinolone resistance-determining region. Antimicrob Agents Chemother.2001Aug 01; 45(8):2378–2380. https://doi.org/10.1128/AAC.45.8.2378-2380.200110.1128/AAC.45.8.2378-2380.20019065911451702Search in Google Scholar

Gibreel TM, Dodgson AR, Cheesbrough J, Fox AJ, Bolton FJ, Upton M. Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. J Antimicrob Chemother. 2012 Feb 01;67(2):346–356. https://doi.org/10.1093/jac/dkr451GibreelTMDodgsonARCheesbroughJFoxAJBoltonFJUptonM.Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. J Antimicrob Chemother.2012Feb 01;67(2):346–356. https://doi.org/10.1093/jac/dkr45110.1093/jac/dkr45122028202Search in Google Scholar

Habibi A, Khameneie MK. Antibiotic resistance properties of uropathogenic Escherichia coli isolated from pregnant women with history of recurrent urinary tract infections. Trop J Pharm Res. 2016 Sep 05;15(8):1745–1750. https://doi.org/10.4314/tjpr.v15i8.21HabibiAKhameneieMK.Antibiotic resistance properties of uropathogenic Escherichia coli isolated from pregnant women with history of recurrent urinary tract infections. Trop J Pharm Res.2016Sep 05;15(8):1745–1750. https://doi.org/10.4314/tjpr.v15i8.2110.4314/tjpr.v15i8.21Search in Google Scholar

Helsana. Helsana-arzneimittelreport. Zürich (Switzerland): Helsana-Gruppe; 2014.Helsana.Helsana-arzneimittelreport. Zürich (Switzerland): Helsana-Gruppe; 2014.Search in Google Scholar

Hirsch EB, Raux BR, Zucchi PC, Kim Y, McCoy C, Kirby JE, Wright SB, Eliopoulos GM. Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates. Int J Antimicrob Agents. 2015 Dec;46(6):642–647. https://doi.org/10.1016/j.ijantimicag.2015.08.012HirschEBRauxBRZucchiPCKimYMcCoyCKirbyJEWrightSBEliopoulosGM.Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates. Int J Antimicrob Agents.2015Dec;46(6):642–647. https://doi.org/10.1016/j.ijantimicag.2015.08.01210.1016/j.ijantimicag.2015.08.01226498988Search in Google Scholar

Hitzenbichler F, Simon M, Holzmann T, Iberer M, Zimmermann M, Salzberger B, Hanses F. Antibiotic resistance in E. coli isolates from patients with urinary tract infections presenting to the emergency department. Infection. 2018 Jun;46(3):325–331. https://doi.org/10.1007/s15010-018-1117-5HitzenbichlerFSimonMHolzmannTIbererMZimmermannMSalzbergerBHansesF.Antibiotic resistance in E. coli isolates from patients with urinary tract infections presenting to the emergency department. Infection.2018Jun;46(3):325–331. https://doi.org/10.1007/s15010-018-1117-510.1007/s15010-018-1117-529368165Search in Google Scholar

Hof H. [Candiduria! What now? Therapy of urinary tract infections with Candida]. Urologe. 2017 Feb;56(2):172–179. https://doi.org/10.1007/s00120-016-0219-xHofH.[Candiduria! What now? Therapy of urinary tract infections with Candida]. Urologe.2017Feb;56(2):172–179. https://doi.org/10.1007/s00120-016-0219-x10.1007/s00120-016-0219-x27590778Search in Google Scholar

Hojabri Z, Mirmohammadkhani M, Darabi N, Arab M, Pajand O. Characterization of antibiotic-susceptibility patterns and virulence genes of five major sequence types of Escherichia coli isolates cultured from extraintestinal specimens: a 1-year surveillance study from Iran. Infect Drug Resist. 2019 Apr;12:893–903. https://doi.org/10.2147/IDR.S199759HojabriZMirmohammadkhaniMDarabiNArabMPajandO.Characterization of antibiotic-susceptibility patterns and virulence genes of five major sequence types of Escherichia coli isolates cultured from extraintestinal specimens: a 1-year surveillance study from Iran. Infect Drug Resist.2019Apr;12:893–903. https://doi.org/10.2147/IDR.S19975910.2147/IDR.S199759647509931118697Search in Google Scholar

Idil N, Candan ED, Rad AY, Aksoz N. High trimethoprim-sulfamethoxazole resistance in ciprofloxacin-resistant Escherichia coli strains isolated from urinary tract infection. Minerva Biotecnol. 2016;28(3):159–163.IdilNCandanEDRadAYAksozN.High trimethoprim-sulfamethoxazole resistance in ciprofloxacin-resistant Escherichia coli strains isolated from urinary tract infection. Minerva Biotecnol.2016;28(3):159–163.Search in Google Scholar

Jakobsen L, Spangholm DJ, Pedersen K, Jensen LB, Emborg HD, Agersø Y, Aarestrup FM, Hammerum AM, Frimodt-Møller N. Broiler chickens, broiler chicken meat, pigs and pork as sources of ExPEC related virulence genes and resistance in Escherichia coli isolates from community-dwelling humans and UTI patients. Int J Food Microbiol. 2010 Aug 15;142(1-2):264–272. https://doi.org/10.1016/j.ijfoodmicro.2010.06.025JakobsenLSpangholmDJPedersenKJensenLBEmborgHDAgersøYAarestrupFMHammerumAMFrimodt-MøllerN.Broiler chickens, broiler chicken meat, pigs and pork as sources of ExPEC related virulence genes and resistance in Escherichia coli isolates from community-dwelling humans and UTI patients. Int J Food Microbiol.2010Aug 15;142(1-2):264–272. https://doi.org/10.1016/j.ijfoodmicro.2010.06.02510.1016/j.ijfoodmicro.2010.06.02520656368Search in Google Scholar

Kadner RJ, Winkler HH. Isolation and characterization of mutations affecting the transport of hexose phosphates in Escherichia coli. J Bacteriol. 1973 Feb;113(2):895–900.KadnerRJWinklerHH.Isolation and characterization of mutations affecting the transport of hexose phosphates in Escherichia coli. J Bacteriol.1973Feb;113(2):895–900.10.1128/jb.113.2.895-900.19732853064347928Search in Google Scholar

Kallonen T, Brodrick HJ, Harris SR, Corander J, Brown NM, Martin V, Peacock SJ, Parkhill J. Systematic longitudinal survey of invasive Escherichia coli in England demonstrates a stable population structure only transiently disturbed by the emergence of ST131. Genome Res. 2017 Aug;27(8):1437–1449. https://doi.org/10.1101/gr.216606.116KallonenTBrodrickHJHarrisSRCoranderJBrownNMMartinVPeacockSJParkhillJ.Systematic longitudinal survey of invasive Escherichia coli in England demonstrates a stable population structure only transiently disturbed by the emergence of ST131. Genome Res.2017Aug;27(8):1437–1449. https://doi.org/10.1101/gr.216606.11610.1101/gr.216606.116553855928720578Search in Google Scholar

Khatri S, Pant ND, Neupane S, Bhandari S, Banjara MR. Biofilm production in relation to extended spectrum beta-lactamase production and antibiotic resistance among uropathogenic Escherichia coli. Janaki Medical College J Med Sci. 2017 Aug 09;5(1):61–63. https://doi.org/10.3126/jmcjms.v5i1.17989KhatriSPantNDNeupaneSBhandariSBanjaraMR.Biofilm production in relation to extended spectrum beta-lactamase production and antibiotic resistance among uropathogenic Escherichia coli. Janaki Medical College J Med Sci.2017Aug 09;5(1):61–63. https://doi.org/10.3126/jmcjms.v5i1.1798910.3126/jmcjms.v5i1.17989Search in Google Scholar

Kim DH, Lees WJ, Kempsell KE, Lane WS, Duncan K, Walsh CT. Characterization of a Cys115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin. Biochemistry. 1996 Jan;35(15):4923–4928. https://doi.org/10.1021/bi952937wKimDHLeesWJKempsellKELaneWSDuncanKWalshCT.Characterization of a Cys115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin. Biochemistry.1996Jan;35(15):4923–4928. https://doi.org/10.1021/bi952937w10.1021/bi952937w8664284Search in Google Scholar

Komp Lindgren P, Karlsson A, Hughes D. Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. Antimicrob Agents Chemother. 2003 Oct 01;47(10):3222–3232. https://doi.org/10.1128/AAC.47.10.3222-3232.2003Komp LindgrenPKarlssonAHughesD.Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. Antimicrob Agents Chemother.2003Oct 01;47(10):3222–3232. https://doi.org/10.1128/AAC.47.10.3222-3232.200310.1128/AAC.47.10.3222-3232.200320115014506034Search in Google Scholar

Kot B, Wicha J, Grużewska A, Piechota M, Wolska K, Obrębska M. Virulence factors, biofilm-forming ability, and antimicrobial resistance of urinary Escherichia coli strains isolated from hospitalized patients. Turk J Med Sci. 2016;46(6):1908–1914. https://doi.org/10.3906/sag-1508-105KotBWichaJGrużewskaAPiechotaMWolskaKObrębskaM.Virulence factors, biofilm-forming ability, and antimicrobial resistance of urinary Escherichia coli strains isolated from hospitalized patients. Turk J Med Sci.2016;46(6):1908–1914. https://doi.org/10.3906/sag-1508-10510.3906/sag-1508-10528081347Search in Google Scholar

Kresken M, Körber-Irrgang B, Biedenbach DJ, Batista N, Besard V, Cantón R, García-Castillo M, Kalka-Moll W, Pascual A, Schwarz R, et al. Comparative in vitro activity of oral antimicrobial agents against Enterobacteriaceae from patients with community-acquired urinary tract infections in three European countries. Clin Microbiol Infect. 2016 Jan;22(1):63.e1–63.e5. https://doi.org/10.1016/j.cmi.2015.08.019KreskenMKörber-IrrgangBBiedenbachDJBatistaNBesardVCantónRGarcía-CastilloMKalka-MollWPascualASchwarzR, Comparative in vitro activity of oral antimicrobial agents against Enterobacteriaceae from patients with community-acquired urinary tract infections in three European countries. Clin Microbiol Infect.2016Jan;22(1):63.e1–63.e5. https://doi.org/10.1016/j.cmi.2015.08.01910.1016/j.cmi.2015.08.01926321667Search in Google Scholar

Lavigne JP, Thibault M, Costa P, Combescure C, Sotto A, Cariou G, Ronco E, Lanotte P, Bruyère F, Coloby P, et al. Resistance and virulence potential of uropathogenic Escherichia coli strains iso lated from patients hospitalized in urology departments: a French prospective multicentre study. J Med Microbiol. 2016 Jun 01;65(6):530–537. https://doi.org/10.1099/jmm.0.000247LavigneJPThibaultMCostaPCombescureCSottoACariouGRoncoELanottePBruyèreFColobyP, Resistance and virulence potential of uropathogenic Escherichia coli strains iso lated from patients hospitalized in urology departments: a French prospective multicentre study. J Med Microbiol.2016Jun 01;65(6):530–537. https://doi.org/10.1099/jmm.0.00024710.1099/jmm.0.00024726953145Search in Google Scholar

Lob SH, Nicolle LE, Hoban DJ, Kazmierczak KM, Badal RE, Sahm DF. Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010–2014. Diagn Microbiol Infect Dis. 2016 Aug;85(4):459–465. https://doi.org/10.1016/j.diagmicrobio.2016.04.022LobSHNicolleLEHobanDJKazmierczakKMBadalRESahmDF.Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010–2014. Diagn Microbiol Infect Dis.2016Aug;85(4):459–465. https://doi.org/10.1016/j.diagmicrobio.2016.04.02210.1016/j.diagmicrobio.2016.04.02227306116Search in Google Scholar

Mann R, Mediati DG, Duggin IG, Harry EJ, Bottomley AL. Metabolic adaptations of uropathogenic E. coli in the urinary tract. Front Cell Infect Microbiol. 2017 Jun 08;7:241. https://doi.org/10.3389/fcimb.2017.00241MannRMediatiDGDugginIGHarryEJBottomleyAL.Metabolic adaptations of uropathogenic E. coli in the urinary tract. Front Cell Infect Microbiol.2017Jun 08;7:241. https://doi.org/10.3389/fcimb.2017.0024110.3389/fcimb.2017.00241546350128642845Search in Google Scholar

McLellan LK, Hunstad DA. Urinary tract infection: pathogenesis and outlook. Trends Mol Med. 2016 Nov;22(11):946–957. https://doi.org/10.1016/j.molmed.2016.09.003McLellanLKHunstadDA.Urinary tract infection: pathogenesis and outlook. Trends Mol Med.2016Nov;22(11):946–957. https://doi.org/10.1016/j.molmed.2016.09.00310.1016/j.molmed.2016.09.003515920627692880Search in Google Scholar

Mellata M, Johnson JR, Curtiss R 3rd. Escherichia coli isolates from commercial chicken meat and eggs cause sepsis, meningitis and urinary tract infection in rodent models of human infections. Zoonoses Public Health. 2018 Feb;65(1):103–113. https://doi.org/10.1111/zph.12376MellataMJohnsonJRCurtissR3rd.Escherichia coli isolates from commercial chicken meat and eggs cause sepsis, meningitis and urinary tract infection in rodent models of human infections. Zoonoses Public Health.2018Feb;65(1):103–113. https://doi.org/10.1111/zph.1237610.1111/zph.1237628703468Search in Google Scholar

Micali S, Isgro G, Bianchi G, Miceli N, Calapai G, Navarra M. Cranberry and recurrent cystitis: more than marketing? Crit Rev Food Sci Nutr. 2014 Jan;54(8):1063–1075. https://doi.org/10.1080/10408398.2011.625574MicaliSIsgroGBianchiGMiceliNCalapaiGNavarraM.Cranberry and recurrent cystitis: more than marketing?Crit Rev Food Sci Nutr.2014Jan;54(8):1063–1075. https://doi.org/10.1080/10408398.2011.62557410.1080/10408398.2011.62557424499122Search in Google Scholar

Michno M, Sydor A, Wałaszek M, Sułowicz W. Microbiology and drug resistance of pathogens in patients hospitalized at the Nephrology Department in the South of Poland. Pol J Microbiol. 2018;67(4):517–524. https://doi.org/10.21307/pjm-2018-061MichnoMSydorAWałaszekMSułowiczW.Microbiology and drug resistance of pathogens in patients hospitalized at the Nephrology Department in the South of Poland. Pol J Microbiol.2018;67(4):517–524. https://doi.org/10.21307/pjm-2018-06110.21307/pjm-2018-061725670330550238Search in Google Scholar

Moreira da Silva RCR, de Oliveira Martins Júnior P, Gonçalves LF, de Paulo Martins V, de Melo ABF, Pitondo-Silva A, de Campos TA. Ciprofloxacin resistance in uropathogenic Escherichia coli isolates causing community-acquired urinary infections in Brasília, Brazil. J Glob Antimicrob Resist. 2017 Jun;9:61–67. https://doi.org/10.1016/j.jgar.2017.01.009Moreira da SilvaRCRde Oliveira Martins JúniorPGonçalvesLFde Paulo MartinsVde MeloABFPitondo-SilvaAde CamposTA.Ciprofloxacin resistance in uropathogenic Escherichia coli isolates causing community-acquired urinary infections in Brasília, Brazil. J Glob Antimicrob Resist.2017Jun;9:61–67. https://doi.org/10.1016/j.jgar.2017.01.00910.1016/j.jgar.2017.01.00928419868Search in Google Scholar

Morrill HJ, Morton JB, Caffrey AR, Jiang L, Dosa D, Mermel LA, LaPlante KL. Antimicrobial Resistance of Escherichia coli Urinary Isolates in the Veterans Affairs Health Care System. Antimicrob Agents Chemother. 2017 May;61(5):e02236-16. https://doi.org/10.1128/AAC.02236-16MorrillHJMortonJBCaffreyARJiangLDosaDMermelLALaPlanteKL.Antimicrobial Resistance of Escherichia coli Urinary Isolates in the Veterans Affairs Health Care System. Antimicrob Agents Chemother.2017May;61(5):e02236-16. https://doi.org/10.1128/AAC.02236-1610.1128/AAC.02236-16540457028193660Search in Google Scholar

Moya-Dionisio V, Díaz-Zabala M, Ibáñez-Fernández A, Suárez-Leiva P, Martínez-Suárez V, Ordóñez-Álvarez FA, Santos-Rodríguez F. [Uropathogen pattern and antimicrobial susceptibility in positive urinary cultures isolates from paediatric patients]. Rev Esp Quimioter. 2016 Jun;29(3):146–150.Moya-DionisioVDíaz-ZabalaMIbáñez-FernándezASuárez-LeivaPMartínez-SuárezVOrdóñez-ÁlvarezFASantos-RodríguezF.[Uropathogen pattern and antimicrobial susceptibility in positive urinary cultures isolates from paediatric patients]. Rev Esp Quimioter.2016Jun;29(3):146–150.Search in Google Scholar

Munkhdelger Y, Gunregjav N, Dorjpurev A, Juniichiro N, Saran tuya J. Detection of virulence genes, phylogenetic group and antibiotic resistance of uropathogenic Escherichia coli in Mongolia. J Infect Dev Ctries. 2017 Jan 30;11(01):51–57. https://doi.org/10.3855/jidc.7903MunkhdelgerYGunregjavNDorjpurevAJuniichiroNSaran tuyaJ.Detection of virulence genes, phylogenetic group and antibiotic resistance of uropathogenic Escherichia coli in Mongolia. J Infect Dev Ctries.2017Jan 30;11(01):51–57. https://doi.org/10.3855/jidc.790310.3855/jidc.790328141590Search in Google Scholar

Naber KG, Schito G, Botto H, Palou J, Mazzei T. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur Urol. 2008 Nov;54(5):1164–1178. https://doi.org/10.1016/j.eururo.2008.05.010NaberKGSchitoGBottoHPalouJMazzeiT.Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur Urol.2008Nov;54(5):1164–1178. https://doi.org/10.1016/j.eururo.2008.05.01010.1016/j.eururo.2008.05.01018511178Search in Google Scholar

Neuner EA, Sekeres J, Hall GS, van Duin D. Experience with fosfomycin for treatment of urinary tract infections due to multidrug-resistant organisms. Antimicrob Agents Chemother. 2012 Nov;56(11):5744–5748. https://doi.org/10.1128/AAC.00402-12NeunerEASekeresJHallGSvan DuinD.Experience with fosfomycin for treatment of urinary tract infections due to multidrug-resistant organisms. Antimicrob Agents Chemother.2012Nov;56(11):5744–5748. https://doi.org/10.1128/AAC.00402-1210.1128/AAC.00402-12348660222926565Search in Google Scholar

Nordstrom L, Liu CM, Price LB. Foodborne urinary tract infections: a new paradigm for antimicrobial-resistant foodborne illness. Front Microbiol. 2013;4:29. https://doi.org/10.3389/fmicb.2013.00029NordstromLLiuCMPriceLB.Foodborne urinary tract infections: a new paradigm for antimicrobial-resistant foodborne illness. Front Microbiol.2013;4:29. https://doi.org/10.3389/fmicb.2013.0002910.3389/fmicb.2013.00029358973023508293Search in Google Scholar

Noyal MJC, Menezes GA, Harish BN, Sujatha S, Parija SC. Simple screening tests for detection of carbapenemases in clinical isolates of nonfermentative Gram-negative bacteria. Indian J Med Res. 2009 Jun;129(6):707–712.NoyalMJCMenezesGAHarishBNSujathaSParijaSC.Simple screening tests for detection of carbapenemases in clinical isolates of nonfermentative Gram-negative bacteria. Indian J Med Res.2009Jun;129(6):707–712.Search in Google Scholar

Ojdana D, Sacha P, Wieczorek P, Czaban S, Michalska A, Jawo rowska J, Jurczak A, Poniatowski B, Tryniszewska E. The occurrence of blaCTX-M, blaSHV, and blaTEM genes in extended-spectrum β-lactamase-positive strains of Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis in Poland. Int J Antibiot. 2014; Art. ID 935842: 7 pages. http://doi.org/10.1155/2014/935842OjdanaDSachaPWieczorekPCzabanSMichalskaAJawo rowskaJJurczakAPoniatowskiBTryniszewskaE.The occurrence of blaCTX-M, blaSHV, and blaTEM genes in extended-spectrum β-lactamase-positive strains of Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis in Poland. Int J Antibiot.2014; Art. ID 935842: 7 pages. http://doi.org/10.1155/2014/93584210.1155/2014/935842Search in Google Scholar

Paniagua-Contreras GL, Monroy-Pérez E, Rodríguez-Moctezuma JR, Domínguez-Trejo P, Vaca-Paniagua F, Vaca S. Virulence factors, antibiotic resistance phenotypes and O-serogroups of Escherichia coli strains isolated from community-acquired urinary tract infection patients in Mexico. J Microbiol Immunol Infect. 2017 Aug;50(4):478–485. https://doi.org/10.1016/j.jmii.2015.08.005Paniagua-ContrerasGLMonroy-PérezERodríguez-MoctezumaJRDomínguez-TrejoPVaca-PaniaguaFVacaS.Virulence factors, antibiotic resistance phenotypes and O-serogroups of Escherichia coli strains isolated from community-acquired urinary tract infection patients in Mexico. J Microbiol Immunol Infect.2017Aug;50(4):478–485. https://doi.org/10.1016/j.jmii.2015.08.00510.1016/j.jmii.2015.08.00526433755Search in Google Scholar

Parajuli NP, Maharjan P, Parajuli H, Joshi G, Paudel D, Sayami S, Khanal PR. High rates of multidrug resistance among uropathogenic Escherichia coli in children and analyses of ESBL producers from Nepal. Antimicrob Resist Infect Control. 2017 Dec;6(1):9. https://doi.org/10.1186/s13756-016-0168-6ParajuliNPMaharjanPParajuliHJoshiGPaudelDSayamiSKhanalPR.High rates of multidrug resistance among uropathogenic Escherichia coli in children and analyses of ESBL producers from Nepal. Antimicrob Resist Infect Control.2017Dec;6(1):9. https://doi.org/10.1186/s13756-016-0168-610.1186/s13756-016-0168-6522564528096977Search in Google Scholar

Petty NK, Ben Zakour NL, Stanton-Cook M, Skippington E, Totsika M, Forde BM, Phan MD, Gomes Moriel D, Peters KM, Davies M, et al. Global dissemination of a multidrug resistant Escherichia coli clone. Proc Natl Acad Sci USA. 2014 Apr 15; 111(15):5694–5699. https://doi.org/10.1073/pnas.1322678111PettyNKBen ZakourNLStanton-CookMSkippingtonETotsikaMFordeBMPhanMDGomes MorielDPetersKMDaviesM, Global dissemination of a multidrug resistant Escherichia coli clone. Proc Natl Acad Sci USA.2014Apr 15; 111(15):5694–5699. https://doi.org/10.1073/pnas.132267811110.1073/pnas.1322678111Search in Google Scholar

Popovic M, Steinort D, Pillai S, Joukhadar C. Fosfomycin: an old, new friend? Eur J Clin Microbiol Infect Dis. 2010 Feb;29(2):127–142. https://doi.org/10.1007/s10096-009-0833-2PopovicMSteinortDPillaiSJoukhadarC.Fosfomycin: an old, new friend?Eur J Clin Microbiol Infect Dis.2010Feb;29(2):127–142. https://doi.org/10.1007/s10096-009-0833-210.1007/s10096-009-0833-2Search in Google Scholar

Pourahmad Jaktaji R, Mohiti E. Study of Mutations in the DNA gyrase gyrA Gene of Escherichia coli. Iran J Pharm Res. 2010 Winter; 9(1):43–48.Pourahmad JaktajiRMohitiE.Study of Mutations in the DNA gyrase gyrA Gene of Escherichia coli. Iran J Pharm Res.2010Winter; 9(1):43–48.Search in Google Scholar

Prasada S, Bhat A, Bhat S, Shenoy Mulki S, Tulasidas S. Changing antibiotic susceptibility pattern in uropathogenic Escherichia coli over a period of 5 years in a tertiary care center. Infect Drug Resist. 2019 May;12:1439–1443. https://doi.org/10.2147/IDR.S201849PrasadaSBhatABhatSShenoy MulkiSTulasidasS.Changing antibiotic susceptibility pattern in uropathogenic Escherichia coli over a period of 5 years in a tertiary care center. Infect Drug Resist.2019May;12:1439–1443. https://doi.org/10.2147/IDR.S20184910.2147/IDR.S201849Search in Google Scholar

Raeispour M, Ranjbar R. Antibiotic resistance, virulence factors and genotyping of Uropathogenic Escherichia coli strains. Antimicrob Resist Infect Control. 2018 Dec;7(1):118. https://doi.org/10.1186/s13756-018-0411-4RaeispourMRanjbarR.Antibiotic resistance, virulence factors and genotyping of Uropathogenic Escherichia coli strains. Antimicrob Resist Infect Control.2018Dec;7(1):118. https://doi.org/10.1186/s13756-018-0411-410.1186/s13756-018-0411-4Search in Google Scholar

Ramírez-Castillo FY, Moreno-Flores AC, Avelar-González FJ, Márquez-Díaz F, Harel J, Guerrero-Barrera AL. An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study. Ann Clin Microbiol Antimicrob. 2018 Dec;17(1):34. https://doi.org/10.1186/s12941-018-0286-5Ramírez-CastilloFYMoreno-FloresACAvelar-GonzálezFJMárquez-DíazFHarelJGuerrero-BarreraAL.An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study. Ann Clin Microbiol Antimicrob.2018Dec;17(1):34. https://doi.org/10.1186/s12941-018-0286-510.1186/s12941-018-0286-5Search in Google Scholar

Regasa Dadi B, Abebe T, Zhang L, Mihret A, Abebe W, Amogne W. Drug resistance and plasmid profile of uropathogenic Escherichia coli among urinary tract infection patients in Addis Abeba. J Infect Dev Ctries. 2018 Aug 31;12(08):608–615. https://doi.org/10.3855/jidc.9916Regasa DadiBAbebeTZhangLMihretAAbebeWAmogneW.Drug resistance and plasmid profile of uropathogenic Escherichia coli among urinary tract infection patients in Addis Abeba. J Infect Dev Ctries.2018Aug 31;12(08):608–615. https://doi.org/10.3855/jidc.991610.3855/jidc.9916Search in Google Scholar

Rezai MS, Salehifar E, Rafiei A, Langaee T, Rafati M, Shafahi K, Eslami G. Characterization of multidrug resistant extended-spectrum beta-lactamase-producing Escherichia coli among uropathogens of pediatrics in North of Iran. BioMed Res Int. 2015;2015:1–7. https://doi.org/10.1155/2015/309478RezaiMSSalehifarERafieiALangaeeTRafatiMShafahiKEslamiG.Characterization of multidrug resistant extended-spectrum beta-lactamase-producing Escherichia coli among uropathogens of pediatrics in North of Iran. BioMed Res Int.2015;2015:1–7. https://doi.org/10.1155/2015/30947810.1155/2015/309478Search in Google Scholar

Rigsby RE, Fillgrove KL, Beihoffer LA, Armstrong RN. Fosfomycin resistance proteins: a nexus of glutathione transferases and epoxide hydrolases in a metalloenzyme superfamily. Methods Enzymol. 2005;401:367–379. https://doi.org/10.1016/S0076-6879(05)01023-2RigsbyREFillgroveKLBeihofferLAArmstrongRN.Fosfomycin resistance proteins: a nexus of glutathione transferases and epoxide hydrolases in a metalloenzyme superfamily. Methods Enzymol.2005;401:367–379. https://doi.org/10.1016/S0076-6879(05)01023-210.1016/S0076-6879(05)01023-2Search in Google Scholar

Riley LW. Pandemic lineages of extraintestinal pathogenic Escherichia coli. Clin Microbiol Infect. 2014 May;20(5):380–390. https://doi.org/10.1111/1469-0691.12646RileyLW.Pandemic lineages of extraintestinal pathogenic Escherichia coli. Clin Microbiol Infect.2014May;20(5):380–390. https://doi.org/10.1111/1469-0691.1264610.1111/1469-0691.1264624766445Search in Google Scholar

Sanchez GV, Babiker A, Master RN, Luu T, Mathur A, Bordon J. Antibiotic resistance among urinary isolates from female outpatients in the United States in 2003 and 2012. Antimicrob Agents Chemother. 2016 May;60(5):2680–2683. https://doi.org/10.1128/AAC.02897-15SanchezGVBabikerAMasterRNLuuTMathurABordonJ.Antibiotic resistance among urinary isolates from female outpatients in the United States in 2003 and 2012. Antimicrob Agents Chemother.2016May;60(5):2680–2683. https://doi.org/10.1128/AAC.02897-1510.1128/AAC.02897-15486248126883714Search in Google Scholar

Sandegren L, Lindqvist A, Kahlmeter G, Andersson DI. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli. J Antimicrob Chemother. 2008 Jun 10;62(3):495–503. https://doi.org/10.1093/jac/dkn222SandegrenLLindqvistAKahlmeterGAnderssonDI.Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli. J Antimicrob Chemother.2008Jun 10;62(3):495–503. https://doi.org/10.1093/jac/dkn22210.1093/jac/dkn22218544599Search in Google Scholar

Sarowska J, Futoma-Koloch B, Jama-Kmiecik A, Frej-Madrzak M, Ksiazczyk M, Bugla-Ploskonska G, Choroszy-Krol I. Virulence factors, prevalence and potential transmission of extraintestinal pathogenic Escherichia coli isolated from different sources: recent reports. Gut Pathog. 2019 Dec;11(1):10. https://doi.org/10.1186/s13099-019-0290-0SarowskaJFutoma-KolochBJama-KmiecikAFrej-MadrzakMKsiazczykMBugla-PloskonskaGChoroszy-KrolI.Virulence factors, prevalence and potential transmission of extraintestinal pathogenic Escherichia coli isolated from different sources: recent reports. Gut Pathog.2019Dec;11(1):10. https://doi.org/10.1186/s13099-019-0290-010.1186/s13099-019-0290-0638326130828388Search in Google Scholar

Schneeberger C, Kazemier BM, Geerlings SE. Asymptomatic bacteriuria and urinary tract infections in special patient groups: women with diabetes mellitus and pregnant women. Curr Opin Infect Dis. 2014 Feb;27(1):108–114. https://doi.org/10.1097/QCO.0000000000000028SchneebergerCKazemierBMGeerlingsSE.Asymptomatic bacteriuria and urinary tract infections in special patient groups: women with diabetes mellitus and pregnant women. Curr Opin Infect Dis.2014Feb;27(1):108–114. https://doi.org/10.1097/QCO.000000000000002810.1097/QCO.000000000000002824296584Search in Google Scholar

Shahbazi S, Asadi Karam MR, Habibi M, Talebi A, Bouzari S. Distribution of extended-spectrum β-lactam, quinolone and car bapenem resistance genes, and genetic diversity among uropathogenic Escherichia coli isolates in Tehran, Iran. J Glob Antimicrob Resist. 2018 Sep;14:118–125. https://doi.org/10.1016/j.jgar.2018.03.006ShahbaziSAsadi KaramMRHabibiMTalebiABouzariS.Distribution of extended-spectrum β-lactam, quinolone and car bapenem resistance genes, and genetic diversity among uropathogenic Escherichia coli isolates in Tehran, Iran. J Glob Antimicrob Resist.2018Sep;14:118–125. https://doi.org/10.1016/j.jgar.2018.03.00610.1016/j.jgar.2018.03.00629581075Search in Google Scholar

Shakhatreh MAK, Swedan SF, Al-Odat MA. Khabour OF. Uropathogenic Escherichia coli (UPEC) in Jordan: prevalence of urovirulence genes and antibiotic resistance. JKSUS. 2018. https://doi.org/10.1016/j.jksus.2018.03.009ShakhatrehMAKSwedanSFAl-OdatMAKhabourOF.Uropathogenic Escherichia coli (UPEC) in Jordan: prevalence of urovirulence genes and antibiotic resistance. JKSUS. 2018. https://doi.org/10.1016/j.jksus.2018.03.00910.1016/j.jksus.2018.03.009Search in Google Scholar

Shenagari M, Bakhtiari M, Mojtahedi A, Atrkar Roushan Z. High frequency of mutations in gyrA gene associated with quinolones resistance in uropathogenic Escherichiacoli isolates from the north of Iran. Iran J Basic Med Sci. 2018 Dec;21(12):1226–1231.ShenagariMBakhtiariMMojtahediAAtrkar RoushanZ.High frequency of mutations in gyrA gene associated with quinolones resistance in uropathogenic Escherichiacoli isolates from the north of Iran. Iran J Basic Med Sci.2018Dec;21(12):1226–1231.Search in Google Scholar

Smelov V, Naber K, Bjerklund Johansen TE. Improved classification of urinary tract infection: future considerations. Eur Urol Suppl. 2016 Jul;15(4):71–80. https://doi.org/10.1016/j.eursup.2016.04.002SmelovVNaberKBjerklund JohansenTE.Improved classification of urinary tract infection: future considerations. Eur Urol Suppl.2016Jul;15(4):71–80. https://doi.org/10.1016/j.eursup.2016.04.00210.1016/j.eursup.2016.04.002Search in Google Scholar

Tabasi M, Karam MR, Habibi M, Mostafavi E, Bouzari S. Genotypic characterization of virulence factors in Escherichia coli isolated from patients with acute cystitis, pyelonephritis and asymptomatic bacteriuria. J Clin Diagn Res. 2016;10(12):DC01-DC07. https://doi.org/10.7860/JCDR/2016/21379.9009TabasiMKaramMRHabibiMMostafaviEBouzariS.Genotypic characterization of virulence factors in Escherichia coli isolated from patients with acute cystitis, pyelonephritis and asymptomatic bacteriuria. J Clin Diagn Res.2016;10(12):DC01-DC07. https://doi.org/10.7860/JCDR/2016/21379.900910.7860/JCDR/2016/21379.9009529642628208853Search in Google Scholar

Talan DA, Takhar SS, Krishnadasan A, Abrahamian FM, Mower WR, Moran GJ; EMERGEncy ID Net Study Group. Fluoroquinolone-resistant and extended-spectrum β-lactamase-producing Escherichia coli infections in patients with pyelonephritis, United States. Emerg Infect Dis. 2016 Sep;22(9). https://doi.org/10.3201/eid2209.160148TalanDATakharSSKrishnadasanAAbrahamianFMMowerWRMoranGJ; EMERGEncy ID Net Study Group.Fluoroquinolone-resistant and extended-spectrum β-lactamase-producing Escherichia coli infections in patients with pyelonephritis, United States. Emerg Infect Dis.2016Sep;22(9). https://doi.org/10.3201/eid2209.16014810.3201/eid2209.160148499433827532362Search in Google Scholar

Tartof SY, Solberg OD, Manges AR, Riley LW. Analysis of a uropathogenic Escherichia coli clonal group by multilocus sequence typing. J Clin Microbiol. 2005 Dec 01;43(12):5860–5864. https://doi.org/10.1128/JCM.43.12.5860-5864.2005TartofSYSolbergODMangesARRileyLW.Analysis of a uropathogenic Escherichia coli clonal group by multilocus sequence typing. J Clin Microbiol.2005Dec 01;43(12):5860–5864. https://doi.org/10.1128/JCM.43.12.5860-5864.200510.1128/JCM.43.12.5860-5864.2005131717516333067Search in Google Scholar

Tchesnokova VL, Rechkina E, Larson L, Ferrier K, Weaver JL, Schroeder DW, She R, Butler-Wu SM, Aguero-Rosenfeld ME, Zerr D, et al. Rapid and extensive expansion in the United States of a new multidrug-resistant Escherichia coli clonal group, sequence type 1193. Clin Infect Dis. 2019 Jan 07;68(2):334–337. https://doi.org/10.1093/cid/ciy525TchesnokovaVLRechkinaELarsonLFerrierKWeaverJLSchroederDWSheRButler-WuSMAguero-RosenfeldMEZerrD, Rapid and extensive expansion in the United States of a new multidrug-resistant Escherichia coli clonal group, sequence type 1193. Clin Infect Dis.2019Jan 07;68(2):334–337. https://doi.org/10.1093/cid/ciy52510.1093/cid/ciy525632184529961843Search in Google Scholar

Tenney J, Hudson N, Alnifaidy H, Li JTC, Fung KH. Risk fac tors for aquiring multidrug-resistant organisms in urinary tract infections: A systematic literature review. Saudi Pharm J. 2018 Jul;26(5):678–684. https://doi.org/10.1016/j.jsps.2018.02.023TenneyJHudsonNAlnifaidyHLiJTCFungKH.Risk fac tors for aquiring multidrug-resistant organisms in urinary tract infections: A systematic literature review. Saudi Pharm J.2018Jul;26(5):678–684. https://doi.org/10.1016/j.jsps.2018.02.02310.1016/j.jsps.2018.02.023603531429991911Search in Google Scholar

Terlizzi ME, Gribaudo G, Maffei ME. Uropathogenic Escherichia coli (UPEC) infections: virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies. Front Microbiol. 2017 Aug 15;8:1566. https://doi.org/10.3389/fmicb.2017.01566TerlizziMEGribaudoGMaffeiME.Uropathogenic Escherichia coli (UPEC) infections: virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies. Front Microbiol.2017Aug 15;8:1566. https://doi.org/10.3389/fmicb.2017.0156610.3389/fmicb.2017.01566555950228861072Search in Google Scholar

Tsuruoka T, Yamada Y. Characterization of spontaneous fosfomycin (phosphonomycin)-resistant cells of Escherichia coli B in vitro. J Antibiot (Tokyo). 1975;28(11):906–911. https://doi.org/10.7164/antibiotics.28.906TsuruokaTYamadaY.Characterization of spontaneous fosfomycin (phosphonomycin)-resistant cells of Escherichia coli B in vitro. J Antibiot (Tokyo). 1975;28(11):906–911. https://doi.org/10.7164/antibiotics.28.90610.7164/antibiotics.28.9061104551Search in Google Scholar

van der Donk CFM, van de Bovenkamp JHB, De Brauwer EIGB, De Mol P, Feldhoff KH, Kalka-Moll WM, Nys S, Thoelen I, Trienekens TAM, Stobberingh EE. Antimicrobial resistance and spread of multi drug resistant Escherichia coli isolates collected from nine urology services in the Euregion Meuse-Rhine. PLoS One. 2012 Oct 17;7(10):e47707. https://doi.org/10.1371/journal.pone.0047707van der DonkCFMvan de BovenkampJHBDe BrauwerEIGBDe MolPFeldhoffKHKalka-MollWMNysSThoelenITrienekensTAMStobberinghEE.Antimicrobial resistance and spread of multi drug resistant Escherichia coli isolates collected from nine urology services in the Euregion Meuse-Rhine. PLoS One.2012Oct 17;7(10):e47707. https://doi.org/10.1371/journal.pone.004770710.1371/journal.pone.0047707347475223082197Search in Google Scholar

van Nieuwkoop C, Bonten TN, Wout JW, Becker MJ, Groeneveld GH, Jansen CL, van der Vorm ER, IJzerman EP, Rothbarth PH, TerMeer-Veringa EM, et al. Risk factors for bacteremia with uropathogen not cultured from urine in adults with febrile urinary tract infection. Clin Infect Dis. 2010 Jun;50(11):e69–e72. https://doi.org/10.1086/652657van NieuwkoopCBontenTNWoutJWBeckerMJGroeneveldGHJansenCLvan der VormERIJzermanEPRothbarthPHTerMeer-VeringaEM, Risk factors for bacteremia with uropathogen not cultured from urine in adults with febrile urinary tract infection. Clin Infect Dis.2010Jun;50(11):e69–e72. https://doi.org/10.1086/65265710.1086/65265720420504Search in Google Scholar

Veeraraghavan B, Shakti L. Advantage and limitations of nitrofurantoin in multi-drug resistant Indian scenario. Indian J Med Microbiol. 2015;33(4):477–481. https://doi.org/10.4103/0255-0857.167350VeeraraghavanBShaktiL.Advantage and limitations of nitrofurantoin in multi-drug resistant Indian scenario. Indian J Med Microbiol.2015;33(4):477–481. https://doi.org/10.4103/0255-0857.16735010.4103/0255-0857.16735026470951Search in Google Scholar

Velasco M, Martínez JA, Moreno-Martínez A, Horcajada JP, Ruiz J, Barranco M, Almela M, Vila J, Mensa J. Blood cultures for women with uncomplicated acute pyelonephritis: are they necessary? Clin Infect Dis. 2003 Oct 15;37(8):1127–1130. https://doi.org/10.1086/378291VelascoMMartínezJAMoreno-MartínezAHorcajadaJPRuizJBarrancoMAlmelaMVilaJMensaJ.Blood cultures for women with uncomplicated acute pyelonephritis: are they necessary?Clin Infect Dis.2003Oct 15;37(8):1127–1130. https://doi.org/10.1086/37829110.1086/37829114523779Search in Google Scholar

Wagenlehner F, Tandogdu Z, Bartoletti R, Cai T, Cek M, Kulchavenya E, Köves B, Naber K, Perepanova T, Tenke P, et al. The global prevalence of infections in urology study: a long-term, worldwide surveillance study on urological infections. Pathogens. 2016 Jan 19;5(1):10. https://doi.org/10.3390/pathogens5010010WagenlehnerFTandogduZBartolettiRCaiTCekMKulchavenyaEKövesBNaberKPerepanovaTTenkeP, The global prevalence of infections in urology study: a long-term, worldwide surveillance study on urological infections. Pathogens.2016Jan 19;5(1):10. https://doi.org/10.3390/pathogens501001010.3390/pathogens5010010481013126797640Search in Google Scholar

Walker E, Lyman A, Gupta K, Mahoney MV, Snyder GM, Hirsch EB. Clinical management of an increasing threat: out patient urinary tract infections due to multidrug-resistant uropathogens. Clin Infect Dis. 2016 Oct 01;63(7):960–965. https://doi.org/10.1093/cid/ciw396WalkerELymanAGuptaKMahoneyMVSnyderGMHirschEB.Clinical management of an increasing threat: out patient urinary tract infections due to multidrug-resistant uropathogens. Clin Infect Dis.2016Oct 01;63(7):960–965. https://doi.org/10.1093/cid/ciw39610.1093/cid/ciw39627313263Search in Google Scholar

Yamaji R, Rubin J, Thys E, Friedman CR, Riley LW. Persistent pandemic lineages of uropathogenic Escherichia coli in a college community from 1999 to 2017. J Clin Microbiol. 2018 Feb 07;56(4): e01834-17. https://doi.org/10.1128/JCM.01834-17YamajiRRubinJThysEFriedmanCRRileyLW.Persistent pandemic lineages of uropathogenic Escherichia coli in a college community from 1999 to 2017. J Clin Microbiol.2018Feb 07;56(4): e01834-17. https://doi.org/10.1128/JCM.01834-1710.1128/JCM.01834-17586983629436416Search in Google Scholar

Yamasaki E, Yamada C, Jin X, Nair GB, Kurazono H, Yamamoto S. Expression of marA is remarkably increased from the early stage of development of fluoroquinolone-resistance in uropathogenic Escherichia coli. J Infect Chemother. 2015 Feb;21(2):105–109. https://doi.org/10.1016/j.jiac.2014.10.007YamasakiEYamadaCJinXNairGBKurazonoHYamamotoS.Expression of marA is remarkably increased from the early stage of development of fluoroquinolone-resistance in uropathogenic Escherichia coli. J Infect Chemother.2015Feb;21(2):105–109. https://doi.org/10.1016/j.jiac.2014.10.00710.1016/j.jiac.2014.10.00725456896Search in Google Scholar

Zacchè MM, Giarenis I. Therapies in early development for the treatment of urinary tract inflammation. Expert Opin Investig Drugs. 2016 May 03;25(5):531–540. https://doi.org/10.1517/13543784.2016.1161024ZacchèMMGiarenisI.Therapies in early development for the treatment of urinary tract inflammation. Expert Opin Investig Drugs.2016May 03;25(5):531–540. https://doi.org/10.1517/13543784.2016.116102410.1517/13543784.2016.116102426934616Search in Google Scholar